Myostatin and activin blockade by engineered follistatin results in hypertrophy and improves dystrophic pathology in mdx mouse more than myostatin blockade alone
Andrea Iskenderian(Takeda (United States)), David E. Ehmann(Baxter (Austria))
Cited by 47
Related Papers
No related papers found
Powered by citation graph analysis